Summary of Key Points
Today, the four major stock indices opened on the rise, but with varying degrees of increase (the Growth Enterprise Market and Science and Technology Innovation sectors saw even stronger gains). There was a clear differentiation among sectors: stocks in the computing power hardware and pharmaceutical industries performed well, while those in the banking and liquor sectors declined. Wuxing Biotech rose by 7% at the opening due to its profits exceeding 10 billion yuan in the first half of the year and an upward revision to its annual earnings forecast. Institutions believe that the significant differences in company performance across sectors in the first half have led investors to adopt a wait-and-see attitude, resulting in short-term market volatility with different sectors taking turns leading the gains.
Detailed Analysis
1. High Opening Prices: A Positive Start, but with Uneven Momentum
A high opening means that the indices were higher than their closing prices from the previous day. All four indices opened higher today, but the increases varied significantly: the Growth Enterprise Market index rose by 1.54%, the Science and Technology Innovation Composite Index by 1.09%, while the Shanghai Composite Index only increased by 0.18%. Why is that?
- The Growth Enterprise Market and Science and Technology Innovation sectors consist mainly of technology and growth-oriented companies (such as those in AI and pharmaceuticals), which performed well today, driving the index gains.
- The Shanghai Composite Index is heavily influenced by heavyweight stocks like banks and liquor companies, which declined today, dragging down the overall index. Overall, the start was positive, but not all stocks rose; it was mainly certain sectors that drove the market.
2. Sector Performance: Computing Power and Pharmaceuticals Outperforming, Banks and Liquor Slowing Down
The fluctuations in sector performance reflect the movement of funds:
- Rebound in Computing Power Hardware (OCS, CPO, Optical Communications): These are AI-related hardware components (such as equipment needed for data centers). They may have been declining recently, but now funds are entering the market to buy (seeking bottom prices), or there is optimism about increasing demand for AI, leading to price increases.
- Pharmaceutical Stocks Soaring: This was mainly driven by positive news from Wuxing Biotech, a leader in the pharmaceutical industry. Its strong performance led investors to believe that the entire pharmaceutical sector might be improving, causing its stocks to rise.
- Banks and Liquor Stocks Pulling Back: These are traditionally stable sectors that may have seen some gains earlier. Currently, funds are shifting to more growth-oriented sectors like computing power and pharmaceuticals, resulting in declines (not due to fundamental weaknesses, but rather a temporary shift in investment focus).
3. Wuxing Biotech's 7% Gain: Outperforming Expectations
Wuxing Biotech's 7% opening increase was due to two positive developments:
- First-Half Net Profit Exceeding 10 Billion Yuan: The company earned over 10 billion yuan in the first half, exceeding market expectations, demonstrating its profitability.
- Upward Revision of Annual Earnings Forecast: The company has raised its annual earnings target (for example, from 15 billion yuan to 18 billion yuan), reflecting confidence in future performance. This positive news encouraged investors to buy its shares.
4. Institutions' Views on the Short Term Market
The perspective from Everbright Securities can be summarized as follows:
- Divergence in Mid-Year Reports: Performance varied greatly among companies, with some posting substantial profits and others suffering heavy losses. Investors are unsure about which stocks to invest in, so they are cautious.
- Short-Term Trend: Trading volume is low, prices are fluctuating within a narrow range, and there will be a structural rotation of sectors (one sector may rise today, another tomorrow). This suggests that a major bull market is unlikely in the short term. To profit, investors should focus on sector rotation and look for opportunities to buy into rising sectors.
5. What Should Ordinary Investors Do?
There's no need to panic, but also avoid blindly chasing high prices:
- If you hold stocks in the computing power or pharmaceutical sectors, you can hold on for now, but don't rush to buy at current high levels (otherwise, you might get trapped in rising prices).
- If you have investments in banks or liquor companies and are stuck with losses, don't rush to sell. These are long-term stable sectors that may see gains once funds return.
- During the mid-year report period (now through the end of August), pay close attention to company performance. Investing in companies with good results and upward earnings forecasts is a safer strategy.
Overall, today's market started well, but with clear sectoral differences. In the short term, there will be limited opportunities for widespread gains.